Multicenter phase II clinical study of the efficiency and safety of capecitabine plus intermittent oxaliplatin with bevacizumab as first-line therapy in patients with metastatic colorectal cancer (VOICE trial)

Phase Ii ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

Phase Ii Clinical Study

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(01)81497-0 ◽

2001 ◽

Vol 37 ◽

pp. S272 ◽

Cited By ~ 5

Author(s):

C. Twelves ◽

C. Butts ◽

J. Cassidy ◽

Th. Conroy ◽

F. DeBraud ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Preliminary Results ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

International Multicenter

A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyt127 ◽

2013 ◽

Vol 43 (11) ◽

pp. 1080-1086 ◽

Cited By ~ 17

Author(s):

T. Nishina ◽

Y. Takano ◽

T. Denda ◽

H. Yasui ◽

K. Takeda ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Study ◽

Cancer Patients ◽

Phase Ii ◽

Recurrent Colorectal Cancer ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase Ii Clinical Study ◽

Colorectal Cancer Patients

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study

BMC Cancer ◽

10.1186/s12885-015-1685-z ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 12

Author(s):

Hitoshi Soda ◽

Hiromichi Maeda ◽

Junichi Hasegawa ◽

Takao Takahashi ◽

Shoichi Hazama ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Preliminary results of an open label, uncontrolled, multicenter, phase II study evaluating the efficacy and safety of xelox plus cetuximab as first-line therapy in patients with metastatic colorectal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15010 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15010-15010 ◽

Cited By ~ 1

Author(s):

S. A. Barroso ◽

E. Sanches ◽

J. M. Ferreira ◽

M. Passos ◽

A. Sá ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Efficacy And Safety ◽

First Line ◽

Open Label ◽

First Line Therapy ◽

Multicenter Phase ◽

An Open‐Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX‐6 as First‐Line Therapy for Metastatic Colorectal Cancer

The Oncologist ◽

10.1634/theoncologist.2014-0028 ◽

2014 ◽

Vol 19 (4) ◽

pp. 350-351 ◽

Cited By ~ 37

Author(s):

Rocio Garcia‐Carbonero ◽

Fernando Rivera ◽

Joan Maurel ◽

Jean‐Pierre M. Ayoub ◽

Malcolm J. Moore ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Open Label ◽

Safety And Efficacy ◽

First Line Therapy ◽

Line Therapy ◽

Open Label Phase

Efficacy and safety findings from a phase II study of capecitabine (X) as first-line therapy in Japanese patients (pts) with advanced/metastatic colorectal cancer (MCRC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3693 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3693-3693 ◽

Cited By ~ 1

Author(s):

K. Shirao ◽

T. Doi ◽

K. Hatake ◽

Y. Arai ◽

K. Yamaguchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504014x13887748696743 ◽

2014 ◽

Vol 21 (4) ◽

pp. 181-191 ◽

Cited By ~ 7

Author(s):

Alberto Muñoz ◽

Carles Pericay ◽

Carlos García-Girón ◽

Vicente Alonso ◽

Rosario Dueñas ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

First Line Therapy ◽

A Four-Arm, Randomized, Multicenter Phase II Trial of Oxaliplatin Combined with Varying Schedules of 5-Fluorouracil as First-line Therapy in Previously Untreated Advanced Colorectal Cancer

Clinical Colorectal Cancer ◽

10.3816/ccc.2008.n.018 ◽

2008 ◽

Vol 7 (2) ◽

pp. 134-139 ◽

Cited By ~ 4

Author(s):

Ramesh K. Ramanathan ◽

Georg A. Bjarnason ◽

Stephen Alan Bernard ◽

Philip Desimone ◽

Theodore Braich ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Cetuximab Plus Mfolfox-6 As First-Line Therapy for Unresectable Liver Metastasis from Colorectal Cancer: An Open, Non-Randomized, Multicenter Phase II Clinical Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)33115-x ◽

2012 ◽

Vol 23 ◽

pp. ix217

Author(s):

S. Cai ◽

W. Zhang ◽

W. Li ◽

Y. Xu ◽

W. Gu ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trial ◽

Liver Metastasis ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

First Line ◽

Unresectable Liver Metastasis ◽

First Line Therapy ◽

Multicenter Phase ◽

Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase�II study

International Journal of Oncology ◽

10.3892/ijo.2019.4709 ◽

2019 ◽

Cited By ~ 2

Author(s):

Benoist Chibaudel ◽

Jean‑Baptiste Bachet ◽

Thierry Andr� ◽

Dominique Auby ◽

J�r�me Desram� ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

First Line Therapy ◽